Appetite Awareness Training + Diabetes Prevention for Type 2 Diabetes
Trial Summary
What is the purpose of this trial?
Black Americans are disproportionately affected by diabetes, with nearly double the rates of type 2 diabetes mellitus (T2DM), compared to non-Hispanic White adults. Though numerous factors affect these disparities, one modifiable risk factor may be that of binge eating (BE), which increases risk for binge-eating disorder (BED), which is associated with severe obesity, and often precedes a T2DM diagnosis, beginning in childhood or adolescence. Nearly 30% of Black women with obesity report binge eating episodes. Furthermore, given that binge and overeating may disparately increase the odds of obesity in Black adults (15-fold increase vs. 6-fold increase in White adults), reducing this behavior will be critical to prevent continued disparities in T2DM diagnosis. Given that Black women have the highest rates of obesity in the nation (57%), report disparate rates of weight gain between young adulthood and mid adulthood, and report disparate rates of emotional eating in adolescence, which is a risk factor for BE, one pathway to reducing disparities in T2DM risk in Black women may be to reduce binge eating and prevent weight gain in emerging adulthood (ages 18-25).
Research Team
Rachel Goode, PhD,MPH,LCSW
Principal Investigator
University of North Carolina, Chapel Hill
Eligibility Criteria
This trial is for Black emergent adults who may be at risk of developing type 2 diabetes due to factors like obesity and binge eating. Participants should have a history or current issue with binge eating but not yet diagnosed with diabetes. It's aimed at preventing the onset of type 2 diabetes by addressing modifiable behaviors.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Appetite Awareness Training (AAT) (Behavioral Intervention)
- Diabetes Prevention Program (DPP) (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
Dr. Peggy P. McNaull
University of North Carolina, Chapel Hill
Chief Medical Officer
MD from Louisiana State University School of Medicine
Dr. Lynne Fiscus
University of North Carolina, Chapel Hill
Chief Executive Officer since 2020
MD from Georgetown University, MPH from UNC